May 13, 2026 07:00AM
Apr 15, 2026 08:45AM
Apr 15, 2026 08:45AM
Mar 30, 2026 07:00AM
Mar 30, 2026 07:00AM
Feb 20, 2026 08:30AM
Feb 20, 2026 08:30AM PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and Potential Accelerated Appr
Jan 22, 2026 08:45AM
Jan 22, 2026 08:45AM
Jan 9, 2026 08:45AM
Jan 9, 2026 08:45AM
Dec 2, 2025 08:32AM
Dec 2, 2025 08:30AM
Nov 13, 2025 07:30AM PDS Biotech Reports Third Quarter 2025 Financial Results and Provides Clinical Programs Update
Nov 11, 2025 03:31PM
Nov 11, 2025 03:31PM
Oct 29, 2025 08:37AM
Oct 29, 2025 08:37AM
Jun 9, 2025 08:00AM
Jun 2, 2025 08:03AM
Jun 2, 2025 08:00AM PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (AS
May 14, 2025 07:30AM
Mar 28, 2025 06:40AM
Mar 27, 2025 07:30AM
Mar 13, 2025 08:00AM
Mar 7, 2025 08:45AM
Mar 7, 2025 08:45AM
Feb 26, 2025 08:00AM PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-Associated Cancers Published in JAMA Oncology
Feb 24, 2025 08:00AM
Feb 24, 2025 08:00AM
Feb 5, 2025 08:02AM
Feb 5, 2025 08:00AM
Dec 3, 2024 08:00AM
Nov 14, 2024 08:00AM
Nov 14, 2024 08:00AM PDS Biotech Provides Clinical Programs Update and Reports Third Quarter 2024 Financial Results
Oct 3, 2024 06:59AM
Oct 2, 2024 08:02AM
Oct 2, 2024 08:00AM
Sep 16, 2024 07:01AM
Sep 16, 2024 07:00AM
Aug 13, 2024 08:00AM
Aug 1, 2024 07:45AM PDS Biotechnology (PDSB) Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
Aug 1, 2024 07:45AM
Mar 27, 2024 07:32AM
Mar 27, 2024 07:30AM
Nov 28, 2023 08:31AM
Nov 28, 2023 08:30AM
Nov 14, 2023 07:30AM
Oct 23, 2023 08:07AM PDS Biotechnology (PDSB) Announces Preliminary Biomarker Study Results in Subset of Advanced HPV-Positive Head and Neck Cancer Patients at ESMO
Oct 23, 2023 08:00AM

322,220 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All